PART B - {Cholesterol Drug Trial Data} It is one question with 4 parts.Show me t

Question

PART B - {Cholesterol Drug Trial Data}

It is one question with 4 parts.Show me the steps using stata app instead of using excel.Thanks.

1. What is the SS for treatment in the medication one-way ANOVA model? ____ Degrees of freedom for treatment? _______ What is the SS error? ________

2. Report and interpret the overall F-test from the one-way ANOVA model for medication.

F=_______ P=_______ ____________________________________________________________________________________________________________________________________________________________________________________

3. Provide the descriptive statistics below.

            Medication                  mean cholesterol          standard deviation cholesterol

            1

            2         

            3

4. Interpret the results of the Bonferroni method for the three medications. ________________________________________________________________

Medication Age Body Mass Index Cholesterol 1 45 22 180 1 57 26 199 1 60 24 201 1 62 23 190 1 59 27 210 1 48 25 211 1 55 22 189 1 56 23 192 1 50 24 216 2 62 28 171 2 65 22 186 2 59 26 170 2 57 25 183 2 72 27 200 2 51 23 181 2 49 24 179 2 64 23 202 2 68 21 174 3 70 26 219 3 55 23 198 3 60 24 202 3 62 24 210 3 53 22 188 3 48 21 191 3 71 25 193 3 65 25 184 3 56 24 200

Explanation / Answer

1. The SS for treatment in the medication one-way ANOVA model __

Degrees of freedom for treatment ___2____

SS error 243.7901

2. Report and interpret the overall F-test from the one-way ANOVA model for medication.

As F>P

We reject the null hypothesis that all the treatment effects are not same

3. Provide the descriptive statistics below.

            Medication                  mean cholesterol          standard deviation cholesterol

            1

3993.611

Related Questions

Navigate

• Browse (All)
• Browse P
• Subjects

---

---

Integrity-first tutoring: explanations and feedback only — we do not complete graded work. Learn more.